Showing results (211-220 of 366) with videos related to
Sort By:
Pageof 37
Journal of the American Heart Association|January 22, 2020
Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac DysfunctionBiniyam G Demissei, Rebecca A Hubbard, Liyong Zhang, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 13, 2012
Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestryNingqi Hou, Yonglan Zheng, Eric R Gamazon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2008
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective studyNoah D Kauff, Susan M Domchek, Tara M Friebel, et al.Breast Cancer Research and Treatment|February 25, 2010
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriersSusan M Domchek, Tara M Friebel, Judy E Garber, et al.Biorxiv : the Preprint Server for Biology|January 16, 2026
High-throughput mapping of 6,888 RAD51D variants identifies distinct biochemical functions needed for homologous recombination and olaparib responseKristie E Darrah, Shelby L Hemker, Yashpal Rawal, et al.JCO Precision Oncology|July 9, 2025
LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair GenesSriram Anbil, Nicholas J Seewald, E Gabriela Chiorean, et al.Nature Communications|August 24, 2017
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriersKara N Maxwell, Bradley Wubbenhorst, Brandon M Wenz, et al.JMIR Research Protocols|August 25, 2025
An eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Patients With Metastatic Cancers: Protocol for a Randomized TrialKimberley T Lee, Briana McLeod, Brian Egleston, et al.Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.British Journal of Cancer|April 20, 2016
Adjuvant ovarian function suppression and cognitive function in women with breast cancerKelly-Anne Phillips, Meredith M Regan, Karin Ribi, et al.Pageof 37